𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9308 Activity of ipilimumab at 10 mg/kg in patients with advanced melanoma is independent of baseline prognostic factors

✍ Scribed by Schadendorf, D.; Wolchok, J.; Neyns, B.; Lebbé, C.; Harmankaya, K.; Verschraegen, C.; Chin, K.; dePril, V.; Hoos, A.; Maio, M.


Book ID
123167229
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
52 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.